Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today it has received the No Objection Letter from Health Canada for its new clinical study with ATIRa .
http://www.biospace.com/news_story.aspx?StoryID=288726&full=1
http://www.biospace.com/news_story.aspx?StoryID=288726&full=1
No comments:
Post a Comment